Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
O-GlcNAc transferase acts as a critical nutritional node for the control of liver homeostasis.
Ortega-Prieto P, Parlati L, Benhamed F, Regnier M, Cavalcante I, Montabord M, Onifarasoaniaina R, Favier M, Pavlovic N, Magusto J, Cauzac M, Pagesy P, Gautheron J, Desdouets C, Guilmeau S, Issad T, Postic C. Ortega-Prieto P, et al. Among authors: parlati l. JHEP Rep. 2023 Aug 12;6(2):100878. doi: 10.1016/j.jhepr.2023.100878. eCollection 2024 Feb. JHEP Rep. 2023. PMID: 38298740 Free PMC article.
Hepatitis C virus cure from direct-acting antivirals and mortality: Are people with and without a history of injection drug use in the same boat? (ANRS CO22 Hepather cohort).
Barré T, Bourlière M, Parlati L, Ramier C, Marcellin F, Protopopescu C, Di Beo V, Cagnot C, Dorival C, Nicol J, Zoulim F, Carrat F, Carrieri P; ANRS/AFEF Hepather Study group. Barré T, et al. Among authors: parlati l. Drug Alcohol Rev. 2024 Mar;43(3):718-731. doi: 10.1111/dar.13802. Epub 2023 Dec 22. Drug Alcohol Rev. 2024. PMID: 38133601
Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors.
Parlati L, Sakka M, Retbi A, Bouam S, Hassani L, Meritet JF, Rufat P, Bonnefont-Rousselot D, Batista R, Terris B, Bellanger A, Thabut D, Vozy A, Spano JP, Coriat R, Goldwasser F, Aractingi S, Sogni P, Pol S, Mallet V; CERTIM Research Group; DEMOSTHENES Research Group. Parlati L, et al. JHEP Rep. 2023 Aug 12;5(12):100880. doi: 10.1016/j.jhepr.2023.100880. eCollection 2023 Dec. JHEP Rep. 2023. PMID: 38074948 Free PMC article.
Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort).
Carrieri P, Bourlière M, Di Beo V, Lusivika-Nzinga C, Ramier C, Antwerpes S, Protopopescu C, Lacombe JM, Pol S, Fontaine H, Mourad A, Carrat F, Duracinsky M, Marcellin F; ANRS/AFEF HEPATHER Study Group. Carrieri P, et al. Qual Life Res. 2023 Dec;32(12):3427-3438. doi: 10.1007/s11136-023-03496-w. Epub 2023 Aug 16. Qual Life Res. 2023. PMID: 37587323
The role of ChREBP in carbohydrate sensing and NAFLD development.
Régnier M, Carbinatti T, Parlati L, Benhamed F, Postic C. Régnier M, et al. Among authors: parlati l. Nat Rev Endocrinol. 2023 Jun;19(6):336-349. doi: 10.1038/s41574-023-00809-4. Epub 2023 Apr 13. Nat Rev Endocrinol. 2023. PMID: 37055547 Review.
New insights into the inter-organ crosstalk mediated by ChREBP.
Carbinatti T, Régnier M, Parlati L, Benhamed F, Postic C. Carbinatti T, et al. Among authors: parlati l. Front Endocrinol (Lausanne). 2023 Feb 27;14:1095440. doi: 10.3389/fendo.2023.1095440. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36923222 Free PMC article. Review.
New targets for NAFLD.
Parlati L, Régnier M, Guillou H, Postic C. Parlati L, et al. JHEP Rep. 2021 Aug 8;3(6):100346. doi: 10.1016/j.jhepr.2021.100346. eCollection 2021 Dec. JHEP Rep. 2021. PMID: 34667947 Free PMC article. Review.
33 results